Cargando…
Mucoprotective effect of ellagic acid in 5 fluorouracil-induced intestinal mucositis model
Intestinal mucositis (IM) is a common side effect of several anticancer medications, including 5-fluorouracil (5-FU), and can lead to treatment disruptions and compromised outcomes. IM has severe clinical effects such as diarrhea, erythematous mucosal lesions, and the development of ulcers accompani...
Autores principales: | AL-hoshary, Dareen Mahmood, Zalzala, Munaf Hashim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375349/ https://www.ncbi.nlm.nih.gov/pubmed/37520490 http://dx.doi.org/10.25122/jml-2023-0052 |
Ejemplares similares
-
Losartan improves intestinal mucositis induced by 5-fluorouracil in mice
por: Oliveira, Maisie Mitchele Barbosa, et al.
Publicado: (2021) -
Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model
por: Huang, Ronglei, et al.
Publicado: (2022) -
Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
por: Tanigawa, Tetsuya, et al.
Publicado: (2011) -
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
por: Ota, Kazuhiro, et al.
Publicado: (2016) -
Gastroduodenal Mucosal Injury in Patients Taking Low-Dose Aspirin and the Role of Gastric Mucoprotective Drugs: Possible Effect of Rebamipide
por: Yamamoto, Takatsugu, et al.
Publicado: (2010)